Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection

Tao Lin1, Wuding Zhou, Conrad A Farrar

  • 1Department of Nephrology and Transplantation, 5th Floor, Thomas Guy House, Guy's Hospital, St. Thomas St., London SE1 9RT, UK.

Insights

Complement effector products drive transplant rejection, but the specific pathway is unknown. This study found classical and lectin pathways, mediated by C4, are dispensable for kidney transplant rejection in mice.

Area of Science:

  • Immunology
  • Transplantation Biology
  • Renal Medicine

Background:

  • Complement system activation is implicated in transplant rejection.
  • The specific complement pathways (classical, lectin, alternative) driving renal allograft rejection remain unclear.

Purpose of the Study:

  • To investigate the role of the classical and lectin complement pathways in mouse kidney transplant rejection.
  • To determine if C4, a component of these pathways, influences graft acceptance or rejection.

Main Methods:

  • Utilized C4-null and wild-type mice in kidney transplantation models.
  • Assessed intragraft C4 gene expression, alloantibody responses, and complement deposition (C3-C9).
  • Evaluated graft acceptance based on donor kidney and recipient C4 expression.

Main Results:

  • Intragraft C4 gene expression increased during rejection.
  • No significant association was found between graft acceptance and C4 presence in donor or recipient.
  • Tubular deposition of C3-C9 occurred irrespective of C4, indicating C4-indispensable complement activation.
  • Alloantibody responses did not differ significantly across experimental groups.

Conclusions:

  • The classical and lectin complement pathways, mediated by C4, do not appear to be the primary drivers of renal allograft rejection in this mouse model.
  • These findings suggest the alternative complement pathway is the main trigger for complement-mediated rejection in the absence of classical and lectin pathway activity.

Related Concept Videos